Aller au contenu principal
Accès ouvert déclaré 2026 article

Magnesium Attenuates Renal Senescence and Fibrosis With Reduced DNA Damage Response and H 3 K 4me3 Enrichment at the p16 INK4a Promoter

0Citations signalées, ce qui n’est pas une note de qualité
3Institutions déclarées
2Pays d’affiliation déclarés

Rattachement africain : jp, us. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

ABSTRACT Renal fibrosis is a final pathway leading to end‐stage renal disease, with cellular senescence contributing to fibrosis and inflammation. Magnesium ions (Mg 2+ ) are implicated in DNA stabilization and epigenetic regulation. In this study, we hypothesized that Mg 2+ ameliorates renal fibrosis in association with reduced DNA damage responses and injury‐induced cellular senescence, along with altered histone H3K4 trimethylation. To test this, we used murine models of radiation‐induced organ injury and renal ischemia–reperfusion injury (IRI), along with primary cultured mouse renal proximal tubular cells. Mice received intraperitoneal MgSO 4 (600 mg/kg) before radiation or IRI, with repeated dosing (300 mg/kg) after IRI. Cultured cells were treated with 6.4 mM MgSO 4 . We demonstrated that Mg 2+ provided protection against radiation injury and reduced radiation‐induced DNA damage markers in renal cells both in vitro and in vivo. Furthermore, Mg 2+ suppressed IRI‐induced morphological alterations, DNA damage, and cellular senescence in the kidneys, while inhibiting renal inflammation and cGAS‐STING pathway activation, along with attenuation of renal fibrosis in IRI model mice. Consistent with these findings, a reduction in the expression of pro‐inflammatory cytokines and fibrosis‐related genes was observed. Finally, Mg 2+ was associated with decreased p16 INK4a transcription and reduced H3K4 trimethylation levels at its promoter in primary renal tubular cells. Our findings suggest that Mg 2+ alleviates renal DNA damage while protecting against inflammation and fibrosis with accompanying epigenetic modulation. Although clinically relevant pharmacological Mg 2+ dosing and therapeutic applicability require further investigation, these insights may inform therapeutic strategies targeting fibrosis and senescence‐related kidney disease.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé, mais le titre doit être comparé manuellement.

Titre Crossref
Magnesium Attenuates Renal Senescence and Fibrosis With Reduced <scp>DNA</scp> Damage Response and <scp>H</scp> 3 <scp>K</scp> 4me3 Enrichment at the <i> p16 <sup>INK4a</sup> </i> Promoter
Date Crossref
14/08/2026
Éditeur
Wiley
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Magnesium in Health and DiseaseAcute Kidney Injury ResearchParathyroid Disorders and Treatments

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.